Rubric Capital Management LP, 10% Owner at TherapeuticsMD, Inc. (TXMD), bought 29,650 shares at $6.09 ($181K) on 2022-12-09, disclosed to the SEC on 2022-12-12.
Open-market purchase of $181k TXMD by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.09 | 14,825 | $90K | 50.0% |
| 2 | $6.09 | 14,825 | $90K | 50.0% |
| Total | $6.09 avg | 29,650 | $181K | 100% |
| Filing → |
| RDUS | BUY | 2022-08-12 | $33.8M | — | Filing → |
| RDUS | BUY | 2022-08-11 | $40K | — | Filing → |
| RDUS | BUY | 2021-12-16 | $2.1M | — | Filing → |